Physician profile
Isha Lopez
NPI 1922393131
$22,260.84
in general payments reported to CMS, 2019-2025
44 companies · $4,680 in 2025
The $4,680 reported for 2025 was more than what 89% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,548 · 2020: $2,071 · 2021: $2,499 · 2022: $3,220 · 2023: $4,413 · 2024: $3,830 · 2025: $4,680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,727.56 |
| Education | $194.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,237.23 | 2019-2025 | |
| Janssen Biotech, INC. | $2,568.73 | 2019-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $2,089.13 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,651.19 | 2019-2025 | Dupixent |
| Leo Pharma INC. | $1,384.41 | 2019-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $1,355.87 | 2019-2025 | |
| Lilly USA, LLC | $1,153.80 | 2019-2025 | Taltz, Ebglyss |
| Sun Pharmaceutical Industries INC. | $1,035.12 | 2019-2025 | Absorica Ld, Winlevi, Blu-U |
| Pfizer INC. | $813.19 | 2019-2025 | |
| Incyte Corporation | $812.60 | 2021-2025 | Opzelura |
| Amgen INC. | $793.70 | 2019-2025 | Otezla, Otezla |
| Arcutis Biotherapeutics, INC. | $623.57 | 2023-2025 | Zoryve |
| Ucb, INC. | $615.43 | 2020-2025 | Bimzelx, Cimzia |
| Dermavant Sciences, INC. | $476.03 | 2022-2024 | Vtama |
| Mayne Pharma Commercial LLC | $401.84 | 2019-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isha Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.